{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T16:08:33Z","timestamp":1776182913093,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100018430","name":"Fondazione IEO-CCM","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100018430","id-type":"DOI","asserted-by":"crossref"}]},{"name":"AIRC, CNR"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1038\/s41375-022-01530-3","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T14:03:33Z","timestamp":1646402613000},"page":"1306-1312","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Co-targeting leukemia-initiating cells and leukemia bulk leads to disease eradication"],"prefix":"10.1038","volume":"36","author":[{"given":"Simona","family":"Moretti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal Kamal","family":"Abdel-Aziz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Ceccacci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella","family":"Pallavicini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1113-4472","authenticated-orcid":false,"given":"Hugues","family":"de Th\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1709-1183","authenticated-orcid":false,"given":"Saverio","family":"Minucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,4]]},"reference":[{"key":"1530_CR1","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.stem.2012.05.007","volume":"10","author":"JE Visvader","year":"2012","unstructured":"Visvader JE, Lindeman GJ. Cancer stem cells: current status and evolving complexities. Cell Stem Cell. 2012;10:717\u201328.","journal-title":"Cell Stem Cell"},{"key":"1530_CR2","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1182\/blood-2016-10-696054","volume":"129","author":"D Thomas","year":"2017","unstructured":"Thomas D, Majeti R. Biology and relevance of human acute myeloid leukemia stem cells. Blood. 2017;129:1577\u201385.","journal-title":"Blood"},{"key":"1530_CR3","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nature20598","volume":"540","author":"SWK Ng","year":"2016","unstructured":"Ng SWK, Mitchell A, Kennedy JA, Chen WC, McLeod J, Ibrahimova N, et al. A 17-gene stemness score for rapid determination of risk in acute leukaemia. Nature. 2016;540:433\u20137.","journal-title":"Nature"},{"key":"1530_CR4","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1038\/leu.2012.39","volume":"26","author":"M Leiva","year":"2012","unstructured":"Leiva M, Moretti S, Soilihi H, Pallavicini I, Peres L, Mercurio C, et al. Valproic acid induces differentiation and transient tumor regression, but spares leukemia-initiating activity in mouse models of APL. Leukemia. 2012;26:1630\u20137.","journal-title":"Leukemia"},{"key":"1530_CR5","doi-asserted-by":"publisher","first-page":"7950","DOI":"10.1073\/pnas.1102454108","volume":"108","author":"CL Chaffer","year":"2011","unstructured":"Chaffer CL, Brueckmann I, Scheel C, Kaestli AJ, Wiggins PA. Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. PNAS. 2011;108:7950\u20135.","journal-title":"PNAS"},{"key":"1530_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmolb.2020.00079","volume":"7","author":"AP Thankamony","year":"2020","unstructured":"Thankamony AP, Saxena K, Murali R, Jolly MK. Cancer stem cell plasticity \u2013 a deadly deal. Front Mol Biosci. 2020;7:1\u201316.","journal-title":"Front Mol Biosci"},{"key":"1530_CR7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1182\/blood-2020-135998","volume":"136","author":"RG Rowe","year":"2020","unstructured":"Rowe RG, Daley GQ, North TE, Marion W, Pikman Y, Harris MH, et al. Mechanisms of leukemia stem cell plasticity revealed by single cell analysis. Blood. 2020;136:32.","journal-title":"Blood"},{"key":"1530_CR8","doi-asserted-by":"crossref","unstructured":"Alcalay M, Zangrilli D, Fagioli M, Pandolfi PP, Mencarelli A, Cocof F Lo, et al. Expression pattern of the RARalpha-PML fusion gene in acute promyelocytic leukemia. PNAS. 1992;89:4840\u20134.","DOI":"10.1073\/pnas.89.11.4840"},{"key":"1530_CR9","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/sj.emboj.7600109","volume":"23","author":"A Insinga","year":"2004","unstructured":"Insinga A, Monestiroli S, Ronzoni S, Carbone R, Pruneri G, Appella E, et al. Impairment of p53 acetylation, stability and function by an oncogenic transcription factor. EMBO J. 2004;23:1144\u201354.","journal-title":"EMBO J"},{"key":"1530_CR10","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/35901","volume":"391","author":"F Grignani","year":"1998","unstructured":"Grignani F, De Matteis S, Nervi C, Tomassoni L, Gelmetti V, Cioce M, et al. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukemia. Nature. 1998;391:815\u20138.","journal-title":"Nature"},{"key":"1530_CR11","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1084\/jem.20050616","volume":"203","author":"H Matsushita","year":"2006","unstructured":"Matsushita H, Scaglioni PP, Bhaumik M, Rego EM, Cai LF, Majid SM, et al. In vivo analysis of the role of aberrant histone deacetylase recruitment and RAR \u03b1 blockade in the pathogenesis of acute promyelocytic leukemia. J Exp Med. 2006;203:821\u20138.","journal-title":"J Exp Med"},{"key":"1530_CR12","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1182\/blood-2015-03-632984","volume":"126","author":"GM Matthews","year":"2015","unstructured":"Matthews GM, Mehdipour P, Cluse LA, Falkenberg KJ, Wang E, Roth M, et al. Functional-genetic dissection of HDAC dependencies in mouse lymphoid and myeloid malignancies. Blood. 2015;126:2392\u2013403.","journal-title":"Blood"},{"key":"1530_CR13","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/nm.1891","volume":"14","author":"R Nasr","year":"2008","unstructured":"Nasr R, Guillemin M, Ferhi O, Soilihi H, Peres L, Berthier C, et al. Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation. Nat Med. 2008;14:1333\u201342.","journal-title":"Nat Med"},{"key":"1530_CR14","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1084\/jem.20122337","volume":"210","author":"J Ablain","year":"2013","unstructured":"Ablain J, Leiva M, Peres L, Fonsart J, Anthony E, de Th\u00e9 H. Uncoupling RARA transcriptional activation and degradation clarifies the bases for APL response to therapies. J Exp Med. 2013;210:647\u201353.","journal-title":"J Exp Med"},{"key":"1530_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-04384-5","volume":"9","author":"J Lehmann-Che","year":"2018","unstructured":"Lehmann-Che J, Bally C, Letouz\u00e9 E, Berthier C, Yuan H, Jollivet F, et al. Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemia. Nat Commun. 2018;9:1\u20138.","journal-title":"Nat Commun"},{"key":"1530_CR16","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1182\/bloodadvances.2019001278","volume":"4","author":"JE Lancet","year":"2020","unstructured":"Lancet JE, Moseley AB, Coutre SE, Deangelo DJ, Othus M, Tallman MS, et al. A phase 2 study of ATRA, arsenic trioxide, and gemtuzumab ozogamicin in patients with high-risk APL (SWOG 0535). Blood Adv. 2020;4:1683\u20139.","journal-title":"Blood Adv"},{"key":"1530_CR17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jim.2009.06.008","volume":"347","author":"Y Hu","year":"2009","unstructured":"Hu Y, Smyth G. ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods. 2009;347:70\u20138.","journal-title":"J Immunol Methods"},{"key":"1530_CR18","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.3324\/haematol.2019.224501","volume":"105","author":"AK Abdel-Aziz","year":"2020","unstructured":"Abdel-Aziz AK, Pallavicini I, Ceccacci E, Meroni G, Saadeldin MK, Varasi M, et al. Tuning mTORC1 activity dictates the response of acute myeloid leukemia to LSD1 inhibition. Haematologica. 2020;105:2105\u2013211.","journal-title":"Haematologica"},{"key":"1530_CR19","first-page":"0","volume":"14","author":"D Kim","year":"2013","unstructured":"Kim D, Pertea G, Trapnell C, Pimentel H, Kelley RSS. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 2013;14:0\u20139.","journal-title":"Genome Biol"},{"key":"1530_CR20","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1093\/nar\/gkq963","volume":"39","author":"PA Fujita","year":"2011","unstructured":"Fujita PA, Rhead B, Zweig AS, Hinrichs AS, Karolchik D, Cline MS, et al. The UCSC genome browser database: Update 2011. Nucleic Acids Res. 2011;39:876\u201382.","journal-title":"Nucleic Acids Res"},{"key":"1530_CR21","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The Sequence Alignment\/Map format and SAMtools. Bioinformatics. 2009;25:2078\u20139.","journal-title":"Bioinformatics"},{"key":"1530_CR22","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics. 2010;26:841\u20132.","journal-title":"Bioinformatics"},{"key":"1530_CR23","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao Y, Smyth GK, Shi W. FeatureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30:923\u201330.","journal-title":"Bioinformatics"},{"key":"1530_CR24","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2009","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2009;26:139\u201340.","journal-title":"Bioinformatics"},{"key":"1530_CR25","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1182\/blood-2002-12-3779","volume":"102","author":"P Westervelt","year":"2003","unstructured":"Westervelt P, Lane A, Pollock J, Oldfather K, Holt M, Zimonjic D, et al. High-penetrance mouse model of acute promyelocytic leukemia with very low levels of PML-RARalpha expression. Blood. 2003;102:1857\u201365.","journal-title":"Blood"},{"key":"1530_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40268-017-0224-6","volume":"18","author":"M Buoli","year":"2018","unstructured":"Buoli M, Serati M, Botturi A, Altamura A. The risk of Thrombocytopenia During Valproic Acid Therapy: a critical summary of available clinical data. Drugs R D. 2018;18:1\u20135.","journal-title":"Drugs R D"},{"key":"1530_CR27","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nrc.2017.103","volume":"18","author":"HD Th\u00e9","year":"2018","unstructured":"Th\u00e9 HD. Differentiation therapy revisited. Nat Rev Cancer. 2018;18:117\u201327.","journal-title":"Nat Rev Cancer"},{"key":"1530_CR28","doi-asserted-by":"publisher","unstructured":"Mcclure JJ, Li X, Chou CJ. Advances and Challenges of HDAC Inhibitors in Cancer Therapeutics. 1st ed. Elsevier Inc., 2018 https:\/\/doi.org\/10.1016\/bs.acr.2018.02.006.","DOI":"10.1016\/bs.acr.2018.02.006"},{"key":"1530_CR29","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1001\/jama.2010.1862","volume":"304","author":"A Gentles","year":"2010","unstructured":"Gentles A, Plevritis S, Majeti R, Alizadeh A. A leukemic stem cell gene expression signature is associated with clinical outcomes in acute myeloid leukemia. JAMA. 2010;304:2706\u201315.","journal-title":"JAMA"},{"key":"1530_CR30","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.4161\/cc.21565","volume":"11","author":"A Romanski","year":"2012","unstructured":"Romanski A, Schwarz K, Keller M, Wietbrauk S, Vogel A, Roos J, et al. Deacetylase inhibitors modulate proliferation and self-renewal properties of leukemic stem and progenitor cells. Cell Cycle. 2012;11:3219\u201326.","journal-title":"Cell Cycle"},{"key":"1530_CR31","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.stem.2019.07.001","volume":"25","author":"MD Mckenzie","year":"2019","unstructured":"Mckenzie MD, Ghisi M, Oxley EP, Ritchie ME, Zuber J, Dickins RA. Interconversion between Tumorigenic and Differentiated States in acute myeloid leukemia article interconversion between tumorigenic and differentiated states in acute myeloid leukemia. Cell Stem Cell. 2019;25:258\u201372.","journal-title":"Cell Stem Cell"},{"key":"1530_CR32","doi-asserted-by":"crossref","unstructured":"Abdel-Aziz AK, Minucci S. Comparing apples with oranges: studying LSD1 inhibitors in cellular assays. Pharmacol Res. 2019;146:104345.","DOI":"10.1016\/j.phrs.2019.104345"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-022-01530-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-022-01530-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-022-01530-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T11:07:03Z","timestamp":1651489623000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-022-01530-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,4]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["1530"],"URL":"https:\/\/doi.org\/10.1038\/s41375-022-01530-3","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,4]]},"assertion":[{"value":"20 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}